A Single-Arm, Open-Label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 11 Mar 2013 Planned end date changed from 1 Feb 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 03 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.